[1] ENCINAS L, LI S Y, RULLAS-TRINCADO J, et al. Contribution of direct InhA inhibitors to novel drug regimens in a mouse model of tuberculosis[J]. Antimicrob Agents and Chemother, 2024, 68(11): e0035724. DOI: 10.1128/aac.00357-24. [2] HOU T Y, WANG J W, SHI L, et al. Clinical efficacy of dexamethasone combined with isoniazid in the treatment of tuberculous meningitis and its effect on peripheral blood T cell subsets[J]. Open Med, 2024, 19(1): 20240948. DOI:10.1515/med-2024-0948. [3] LI Y, WW LUO, CHENG X, et al. Curcumin attenuates isoniazid‐induced hepatotoxicity by upregulating the SIRT1/PGC-1 pathway[J]. J Appl Toxicol, 2022, 42(8):801-812. DOI:10.1002/jat.4288. [4] ALVAREZ-ARANGO S, KUMAR M, CHOW T G, et al. Non-IgE-mediated immediate drug-induced hypersensitivity reactions[J]. J Allergy Clin Immunol, 2024,12(5): 1109-1119. DOI: 10.1097/MOP.0000000000001395. [5] PICHLER W J, THOO L, YERLY D. Drug hypersensitivity and eosinophilia: the decisive role of p-i stimulation [J]. Allergy, 2023, 78(10):2596-2605. DOI: 10.1111/all.15795. [6] MILLE B, INGEN-HOUSZ-ORO, PROST N, et al. High frequency of eosinophilia and viral reactivation in drug hypersensitivity in patients with severe acute respiratory syndrome coronavirus 2 infection[J]. J Eur Acad Dermatol Venereol, 2021, 36(4): e256-e257. DOI:10. 1111/jdv.17885. [7] TSU-MAN C, CHUN-BING C, CHUN-WEI L, et al. CCR8/CCL1 and CXCR3/CXCL10 axis-mediated memory T-cell activation in patients with recalcitrant drug-induced hypersensitivity[J]. Br J Dermatol, 2024, 192(2): 293-305. DOI:10.1093/bjd/ljae375. [8] CHEN D, HOU X. Aspartame carcinogenic potential revealed through network toxicology and molecular docking insights[J]. Sci Rep, 2024, 14(1): 11492. DOI:10.1038/s41598-024-62461-w. [9] GUO Y, LI N. Network toxicology and molecular docking to investigative the non-acetylcholinesterase mechanisms and targets of cardiotoxicity injury induced by organophosphorus pesticides[J]. Medicine, 2024, 103(41): e39963. DOI:10.1097/MD.00000000000 39963. [10] LI J, BI H. Clarification of the molecular mechanisms underlying glyphosate-induced major depressive disorder: a network toxicology approach[J]. Ann Gen Psychiatry, 2024, 23(1):8. DOI:10.1186/s12991-024-00491-4. [11] ZENG Z, HU J, XIAO G, et al. Integrating network toxicology and molecular docking to explore the toxicity of the environmental pollutant butyl hydroxyanisole: An example of induction of chronic urticaria[J]. Heliyon, 2024, 10(15): e35409. DOI: 10.1016/J. HELIYON. 2024. E37003. [12] KARAKU F. Network toxicology for the cardiovascular toxicity analysis of tyrosine kinase inhibitors[J]. Ankara Ecz Fak Derq, 2024, 48(3):929. DOI:10.33483/ jfpau.1478733. [13] PICHLER W J, WATKINS S, YERLY D. Risk assessment in drug hypersensitivity: detecting small molecules which outsmart the immune system[J]. Front Allergy, 2022, 3: 827893. DOI:10.3389/falgy.2022.827893. [14] ZHANG H, WANG B K, ZHANG Y F, et al. Nomenclature of allergy: past and present[J]. Transfus Clin Biol, 2023, 30(1): 22-24. DOI:10.1016/j.tracli.2022. 08.148. [15] BIRCHER A J. Classification and terminology of drug hypersensitivity reactions[M]. Cham: Springer, 2022: 3-9. [16] MAYORGA C, ARIZA A, MUNOZ-CANO I T M J. Biomarkers of immediate drug hypersensitivity[J]. Allergy, 2024, 79(3):601-612. DOI:10.1111/all.15933. [17] CARDONA V, ANSOTEGUI IJ, EBISAWA M, et al. World allergy organization anaphylaxis guidance 2020[J]. World Allergy Organ J, 2020, 13(10):100472. DOI: 10.1016/j. waojou.2020. 100472. [18] MATOUR E, ASADI Z T, DEILAMI A A, et al. MiR-34c-5p inhibition affects Bax/Bcl2 expression and reverses bortezomib resistance in multiple myeloma cells[J]. Indian J Hematol Blood Transfus, 2024, 40(4):596-603. DOI:10.1007/s12288-024-01742-w. [19] 李霞,穆建梅,王志婕,等. miR-153-3p靶向结合BCL2基因调控鼻咽癌细胞增殖,凋亡和周期的实验研究[J].宁夏医学杂志, 2023, 45(5):385-388. DOI: 10.13621/j.1001-5949.2023.05.0385. [20] JASSIM MMA, NAJI SA, MAHMOOD MM. BRCA1, BCL2 and the RB tumor suppressor have abnormal expressions in lung cancer[J]. Res J Pharm and Technol, 2022, 15(9):4083-4087. DOI:10.52711/0974-360x.2022.00685. [21] KERN A, ALBARRAN-ZECKLER R, WALSH H, et al. Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism[J]. Neuron, 2012, 73(2):317-332. DOI:10.1016/ j. neuron.2011.10.038. [22] MITRA S, LEONARD W J. Biology of IL-2 and its therapeutic modulation: mechanisms and strategies[J]. J Leukoc Biol, 2018, 103(4):643-655. DOI:10.1002/JLB.2RI0717-278R. [23] WANG L, ROSSI R M, CHEN, et al. A functional mechanism for a non-coding variant near AGTR2 associated with risk for preterm birth[J]. BMC Med, 2023, 21(1):258. DOI:10. 1186/s12916-023-02973-w. [24] TAYLER H M, MACLACHLAN R, GÜZEL, et al. Altered gene expression within the renin-angiotensin system in normal aging and dementia[J]. J Gerontol A Biol Sci Med Sci, 2024, 79(1): glad241. DOI: 10.1093/gerona/ glad241. [25] AJJOUR H, LENZINI L, PALLAFACCHINA G, et al. Abstract P103: assessment of angiotensin II-induced calcium signals in primary human adrenocortical cells[J]. Hypertension, 2024, 81(Suppl_1): AP103. DOI: 10.1161/hyp.81.suppl_1.P103.. [26] SILVESTRI R, V. Nicolì, GANGADHARANNAMBIAR P, et al. Calcium signalling pathways in prostate cancer initiation and progression[J]. Nat Rev Urol, 2023, 20(9):524-543. DOI:10.1038/s41585-023-00738-x. [27] BELKACEMI A, BECK A, WARDAS B, et al. IP3-dependent Ca2+ signals are tightly controlled by Cavβ3, but not by Cavβ1, 2 and 4 [J]. Cell Calcium, 2022, 104: 102573. DOI: 10.1016/j.ceca.2022. 102573. [28] KHAIRULLIN A E, EFIMOVA D V, EREMEEV A A, et al. Effect of spinal cord injury on P2 signaling in the cholinergic synapse[J]. J Evol Biochem Phys,2023, 59(3):822-830. DOI:10.1134/ S0022093023030158. [29] PAMELA J Roqué, BARRIA A, Zhang X, et al. Synaptogenesis by cholinergic stimulation of astrocytes[J]. Neurochem Res, 2023, 48(10):3212-3227. DOI:10.1007/s11064-023-03979-9. [30] PANEK M G, KARBOWNIK M S, GÓRSKI K M, et al. New insights into the regulation of TGF-β/Smad and MPK signaling pathway gene expressions by nasal allergen and methacholine challenge test in asthma.[J]. Clin Transl Allergy, 2022, 12(7): e12172. DOI:10.1002/CLT2.12172. ( |